Cefdinir Impurity 1
71091-93-5
Pharmaceutical Grade
Guangzhou
10mg
2023-12-31
Reference Listed Drugs,Excipients,Intermediates,Impurity Standards,API
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
Cefdinir impurity C
Other Name:Cefdinir impurity C;UNII-G9Y9M0S93M;71091-93-5;G9Y9M0S93M;Cefdinir Impurity 1 (Impurity G);(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyiminoacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;SCHEMBL5487622;(6R ,7R )-7-((Z )-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(hydroxyimino)acetyl)amino)-3-methyl-8-oxo-, (6R-(6alpha,7beta(Z)))-;5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2Z)-2-(2-amino-4-thiazolyl)-2-(hydroxyimino)acetyl)amino)-3-methyl-8-oxo-, (6R,7R)-
CAS No.:71091-93-5
Molecular Formula:C13H13N5O5S2
InChIKeys:FMPXXFJEIVCXCL-ODXWQDPNSA-N
Molecular Weight:383.4
Exact Mass:383.03581088
UNII:G9Y9M0S93M
Categories:
Characteristics -
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
Reference Listed Drugs,Excipients,Intermediates,Impurity Standards,API
-
Location:
Room 1201, Room 1203, 181 Science Avenue, Huangpu District, Guangzhou, China
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
180
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
201-300
-
Year of Establishment:
1999
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product